蓝帆医疗: 第六届董事会第二十七次会议决议公告

Group 1 - The company held its 27th meeting of the 6th Board of Directors on August 14, 2025, with 7 out of 8 directors participating [1] - The Board approved a proposal to lower the conversion price of "Lanfang Convertible Bonds" to 11.50 RMB per share, effective from August 15, 2025 [2] - The decision was made considering the company's future development prospects and stock price trends, with a unanimous vote of 8 in favor [2] Group 2 - The company will reconvene the Board if the conversion price triggers further downward adjustments in the future [2] - The meeting procedures complied with the Company Law of the People's Republic of China and the company's articles of association [1] - The decision and related documents will be disclosed in designated media outlets [2][3]